Sanfilippo John B & Son vs Utz Brands
JBSS and UTZ side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How JBSS and UTZ compare
Utz Brands is the larger company, worth 3.0 times as much as Sanfilippo John B & Son ($2.1B against $691M).
Sanfilippo John B & Son grew revenue faster over the last twelve months (3.1% versus 0.48% for Utz Brands).
Sanfilippo John B & Son keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −2.7% at Utz Brands.
Both pay dividends: Sanfilippo John B & Son yields 7.6% and Utz Brands 1.8%.
Sanfilippo John B & Son scores higher on the StockData Score (20 against 4 for Utz Brands), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | JBSS | UTZ |
|---|---|---|
| Size and price | ||
| Market cap | $691M | $2.1B |
| Share price | $59.06 | $14.28 |
| Change, 1 year | −12.7% | 36.4% |
| Change, 5 years | −29.8% | −10.4% |
| Beta (5Y) | 0.33 | 0.43 |
| Employees | 1,770 | 3,100 |
| StockData Score | ||
| Total score | 20 (better) | 4 |
| Valuation score | 6 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 3 (better) | 1 |
| Valuation | ||
| P/E | 12.4× | – |
| P/S | 0.6× (better) | 1.4× |
| P/B | 1.9× (better) | 3.0× |
| EV/EBITDA | 6.7× (better) | 46.3× |
| P/FCF | 22.7× (better) | 857× |
| FCF yield | 4.4% (better) | 0.12% |
| Fair value | $89.86 | $4.83 |
| Margin of safety | 34.3% (better) | −196% |
| Growth | ||
| Revenue growth (TTM) | 3.1% (better) | 0.48% |
| Revenue growth, 5Y average | 6.5% | – |
| Net income growth (TTM) | −14.6% (better) | −789% |
| EPS growth (TTM) | −14.9% (better) | −714% |
| EPS growth, 5Y average | 0.35% | – |
| Profitability | ||
| Gross margin | 17.7% | 24.6% (better) |
| Operating margin | 7.0% (better) | −1.1% |
| Net margin | 4.8% (better) | −2.7% |
| FCF margin | 2.6% (better) | 0.17% |
| Return on equity | 15.4% (better) | −5.5% |
| Return on invested capital | 15.0% (better) | −0.81% |
| Financial health | ||
| Debt / equity | 0.13 (better) | 1.30 |
| Net debt / EBITDA | 0.43 (better) | 10.75 |
| Interest coverage | 38.3× (better) | −0.4× |
| Current ratio | 1.96 (better) | 1.07 |
| Altman Z-score | 4.27 (better) | 1.14 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 7.6% (better) | 1.8% |
| Payout ratio | 93.4% | – |
| Years of dividend growth | 1 | – |
| Dividend growth, 5Y average | −4.4% | – |
| Shareholder yield | 7.6% (better) | 1.8% |
| Ownership | ||
| Held by institutions | 73.1% | 53.5% |
| Held by insiders | 20.2% | 43.0% |
| Insider net buying, 12 months | −$1.4M | $13.6K (better) |
| Short interest, % of float | 6.3% | 6.4% |
Go deeper
- JBSS stock overview
- JBSS income statement
- JBSS valuation and score
- UTZ stock overview
- UTZ income statement
- UTZ valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.